163 related articles for article (PubMed ID: 17335715)
21. Gut microflora in the pathogenesis of the complications of cirrhosis.
Garcia-Tsao G; Wiest R
Best Pract Res Clin Gastroenterol; 2004 Apr; 18(2):353-72. PubMed ID: 15123075
[TBL] [Abstract][Full Text] [Related]
22. Long-term cannabinoid type 2 receptor agonist therapy decreases bacterial translocation in rats with cirrhosis and ascites.
Yang YY; Hsieh SL; Lee PC; Yeh YC; Lee KC; Hsieh YC; Wang YW; Lee TY; Huang YH; Chan CC; Lin HC
J Hepatol; 2014 Nov; 61(5):1004-13. PubMed ID: 24953022
[TBL] [Abstract][Full Text] [Related]
23. Microbiome and bacterial translocation in cirrhosis.
Gómez-Hurtado I; Such J; Francés R
Gastroenterol Hepatol; 2016 Dec; 39(10):687-696. PubMed ID: 26775042
[TBL] [Abstract][Full Text] [Related]
24. Proteomic evidence of bacterial peptide translocation in afebrile patients with cirrhosis and ascites.
Caño R; Llanos L; Zapater P; Pascual S; Bellot P; Barquero C; Pérez-Mateo M; Such J; Francés R
J Mol Med (Berl); 2010 May; 88(5):487-95. PubMed ID: 20087563
[TBL] [Abstract][Full Text] [Related]
25. Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence.
Llovet JM; Bartolí R; March F; Planas R; Viñado B; Cabré E; Arnal J; Coll P; Ausina V; Gassull MA
J Hepatol; 1998 Feb; 28(2):307-13. PubMed ID: 9580278
[TBL] [Abstract][Full Text] [Related]
26. [Spontaneous bacterial peritonitis].
Skladaný Ľ; Kasová S; Purgelová A; Bystrianska N; Adamcová-Selčanová S
Klin Mikrobiol Infekc Lek; 2016 Dec; 22(4):136-140. PubMed ID: 28147426
[TBL] [Abstract][Full Text] [Related]
27. Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis.
Bauer TM; Fernández J; Navasa M; Vila J; Rodés J
J Hepatol; 2002 Apr; 36(4):501-6. PubMed ID: 11943421
[TBL] [Abstract][Full Text] [Related]
28. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites.
Such J; Francés R; Muñoz C; Zapater P; Casellas JA; Cifuentes A; Rodríguez-Valera F; Pascual S; Sola-Vera J; Carnicer F; Uceda F; Palazón JM; Pérez-Mateo M
Hepatology; 2002 Jul; 36(1):135-41. PubMed ID: 12085357
[TBL] [Abstract][Full Text] [Related]
29. Nucleotide-Binding Oligomerization Domain-Containing Protein 2 Variants in Patients with Spontaneous Bacterial Peritonitis.
Harputluoglu MM; Dertli R; Otlu B; Demirel U; Yener O; Bilgic Y; Erdogan MA; Atayan Y; Cagin YF
Dig Dis Sci; 2016 Jun; 61(6):1545-52. PubMed ID: 26725065
[TBL] [Abstract][Full Text] [Related]
30. Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis.
Francés R; Zapater P; González-Navajas JM; Muñoz C; Caño R; Moreu R; Pascual S; Bellot P; Pérez-Mateo M; Such J
Hepatology; 2008 Mar; 47(3):978-85. PubMed ID: 18306221
[TBL] [Abstract][Full Text] [Related]
31. Application of next-generation sequencing to study ascitic microbiome in cirrhotic patients with or without spontaneous bacterial peritonitis.
Feng Y; Chen CL; Chen TH; Liang YH; Chen HL; Lin CY; Chiu CH
J Microbiol Immunol Infect; 2015 Oct; 48(5):504-9. PubMed ID: 25305707
[TBL] [Abstract][Full Text] [Related]
32. Spontaneous bacterial peritonitis in liver cirrhosis: treatment and prophylaxis.
Arroyo V; Navasa M; Rimola A
Infection; 1994; 22 Suppl 3():S167-75. PubMed ID: 7843826
[TBL] [Abstract][Full Text] [Related]
33. The influence of antibiotic treatment on the dynamics of oxidative stress in spontaneous bacterial peritonitis.
Dănulescu RM; Ciobică A; Stanciu C; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2013; 117(3):598-604. PubMed ID: 24502022
[TBL] [Abstract][Full Text] [Related]
34. Study on ascitic fluid complement 3 level in cirrhotic patients with spontaneous bacterial peritonitis and without spontaneous bacterial peritonitis.
Mustafa G; Khan M; Alam K; Rahman S; Ahmad N; Alam S; Ahmed S
Hepatogastroenterology; 2007; 54(79):1905-7. PubMed ID: 18251125
[TBL] [Abstract][Full Text] [Related]
35. [Spontaneous bacterial peritonitis].
Strauss E; Caly WR
Rev Soc Bras Med Trop; 2003; 36(6):711-7. PubMed ID: 15049112
[TBL] [Abstract][Full Text] [Related]
36. Detection of ascitic fluid infections in patients with liver cirrhosis and ascites.
Mostafa MS; El-Seidi EA; Kassem AM; Shemis MA; Saber M; Michael MN
Arab J Gastroenterol; 2011 Mar; 12(1):20-4. PubMed ID: 21429450
[TBL] [Abstract][Full Text] [Related]
37. Functional polymorphisms of innate immunity receptors are not risk factors for the non-SBP type bacterial infections in cirrhosis.
Dinya T; Tornai T; Vitalis Z; Tornai I; Balogh B; Tornai D; Antal-Szalmas P; Sumegi A; Andrikovics H; Bors A; Tordai A; Papp M
Liver Int; 2018 Jul; 38(7):1242-1252. PubMed ID: 29235260
[TBL] [Abstract][Full Text] [Related]
38. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis.
Bauer TM; Steinbrückner B; Brinkmann FE; Ditzen AK; Schwacha H; Aponte JJ; Pelz K; Kist M; Blum HE
Am J Gastroenterol; 2001 Oct; 96(10):2962-7. PubMed ID: 11693333
[TBL] [Abstract][Full Text] [Related]
39. The prognostic significance of bacterial DNA in patients with decompensated cirrhosis and suspected infection.
Bruns T; Reuken PA; Stengel S; Gerber L; Appenrodt B; Schade JH; Lammert F; Zeuzem S; Stallmach A
Liver Int; 2016 Aug; 36(8):1133-42. PubMed ID: 26901072
[TBL] [Abstract][Full Text] [Related]
40. Treatment of Spontaneous Bacterial Peritonitis.
Salerno F; La Mura V
Dig Dis; 2015; 33(4):582-5. PubMed ID: 26159277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
